Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 23. Oktober 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16842  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 336829  
   
Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study.
Hered Cancer Clin Pract
Wuraola FO, Ramruthan J, Mango VL, Sunday-Nweke N, Agodirin O, Dare A, Aderounmu AA, Ogunyemi M, Olawale B, Lawal S, Santiago AT, Olasehinde O, Adisa AO, Reel E, Alatise OI, Cil TD.
PMID: 42907996 [PubMed]


Clinician vs. self-assessment of mFG hirsutism scores in PCOS: can patient self-assessment serve as a reliable screening and triage tool?
BMC Womens Health
Su D, Gao Y, Sun X, Su H, Ma R, Liu Y, Jiang X, Zhang M, Lei T, Tan C, Yang X.
PMID: 42907968 [PubMed - indexed for MEDLINE]


Artificial intelligence in breast cancer pharmacotherapy: Treatment optimization, medication safety, and the evolving role of oncology pharmacists.
J Oncol Pharm Pract
Abuzaid AAA.
PMID: 42907964 [PubMed - as supplied by publisher]


From cytoreduction to precision oncology: evolution of ovarian cancer therapy.
J Ovarian Res
Saed GM, Detti L, Massad D, Basha A, Morris RT.
PMID: 42907928 [PubMed - indexed for MEDLINE]


Lactate-driven metabolic-epigenetic reprogramming in breast cancer: immune evasion and therapeutic resistance.
Clin Epigenetics
Sun L, Wang L, Zeng W, Zeng S.
PMID: 42907906 [PubMed - indexed for MEDLINE]


The economic burden of cervical cancer in Addis Ababa: a matched case-control study.
BMC Health Serv Res
Shimels T, Gashawbeza B, Fenta TG.
PMID: 42907892 [PubMed - indexed for MEDLINE]


Reprogramming tumor-associated macrophages in breast cancer: from myeloid plasticity and tumor-promoting programs to CAR-macrophage therapy.
J Hematol Oncol
Heydari F, Derakhshani M, Naghinezhad J.
PMID: 42907869 [PubMed - indexed for MEDLINE]


Construction and validation of a predictive model for fear of progression among postoperative patients with breast cancer: a multi-center cross-sectional study.
BMC Cancer
Tian L, Feng X, Liu M, Jiang J, Qin Q, Xie W, Guo Y, Zhao J, Liang Y, Ma X, Jiang L.
PMID: 42907839 [PubMed - indexed for MEDLINE]


Developing a Culturally Tailored COVID-19 Educational Website for Latina and Black/African American Breast Cancer Survivors: Findings from a Community-Engaged Study.
J Racial Ethn Health Disparities
Gómez V, Martinez V, Sedeño-Delgado D, Argueta-Contreras J, Rodriguez J, Jones TD, Beale J, Campos C, Graves KD, Darlington D, Hurtado-de-Mendoza A.
PMID: 42907706 [PubMed - as supplied by publisher]


Mass Spectrometry-Based Proteomics Analysis of Breast Milk for Breast Cancer Biomarker Discovery: An Update.
Adv Exp Med Biol
Arshad A, Aslebagh R, Petre BA, Uzunoglu B, Flack R, Arcaro KF, Darie CC.
PMID: 42907637 [PubMed - indexed for MEDLINE]


Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study.
Target Oncol
Gökdere ZS, , Bilgetekin , Baytemur NK, Seyyar M, Yaz, Gümü, Akay S, Günenç D, Karao, Dama PE, Haf, Menek, Karadurmu, Özüdo, Uyar GC, Turhan G, Köylü B, Turan F, Cengiz AN, Güren AK, Bütün O, Salman CB, Geçgel A, , Asarkaya E, Y, Ünlü A, , Usta EA, Kanmaz H, Esin E, Erdemo, Y, Aykan MB, Ku, , Çubukçu E, Semiz HS, Selçukbiricik F, , Sar, Karabulut B, Odaba, Bayram E, Do, Öztürk B, Güç ZG, , Çakar B, Gökmen E, Öksüzo, Çabuk D, Aksoy S, Y.
PMID: 42907609 [PubMed - as supplied by publisher]


Health literacy as a determinant of psychosocial and functional outcomes in individuals at risk for lymphedema.
Support Care Cancer
Aslan SG, , Köylü SU, Mand.
PMID: 42907575 [PubMed - indexed for MEDLINE]


Frailty assessment in ovarian cancer: a systematic review of measurement definitions, methods, and clinical implications.
Int J Gynecol Cancer
Castelo-Loureiro A, Alqaisi H, Fazelzad R, Rodríguez-Couso M, Noronha MM, Soto-Perez-de-Celis E, Lheureux S, Oza AM, Madariaga A.
PMID: 42907257 [PubMed - as supplied by publisher]


Understanding and Addressing Anovulatory Infertility.
Endocrinol Metab Clin North Am
Violette CJ, Eaton JL.
PMID: 42907060 [PubMed - indexed for MEDLINE]


Redefining Polycystic Ovary Syndrome: New Phenotypic Classifications and Implications.
Endocrinol Metab Clin North Am
Vafea MT, Dunaif A.
PMID: 42907054 [PubMed - indexed for MEDLINE]


Hormone Therapy Considerations for Breast Cancer Survivors and High-Risk Women.
Endocrinol Metab Clin North Am
Sanserino K.
PMID: 42907052 [PubMed - indexed for MEDLINE]


Neurofibromin in Breast Cancer.
Crit Rev Oncol Hematol
Parsyan A.
PMID: 42906729 [PubMed - as supplied by publisher]


Patterns of central nervous system and leptomeningeal involvement in advanced breast cancer with invasive lobular histology: a large multicenter study with a focus on estrogen receptor-positive/HER2-negative disease.
ESMO Open
Miglietta F, Vernieri C, Giarratano T, Griguolo G, Bottosso M, Vingiani A, Piacentini F, Cacciatore M, Botticelli A, Fotia G, Napolitano P, Landa G, Vernaci GM, Di Liso E, Casadei L, Palleschi D, Pruneri G, Dei Tos AP, Guarneri V, Dieci MV.
PMID: 42906524 [PubMed - as supplied by publisher]


Parity, breastfeeding, and reproductive timing are associated with tumour-infiltrating lymphocytes in hormone receptor-negative breast cancer: a population-based cohort study.
ESMO Open
Gabrielsen E, Wirsing A, Wilsgaard T, Thune I, Frydenberg H, Lofterød T, Mortensen E, Nalwoga H, Akslen LA, Haugnes HS, Blix ES.
PMID: 42906523 [PubMed - as supplied by publisher]


The Role of Natural Killer Cells and Immune Factors in Implantation Failure in Women With Polycystic Ovary Syndrome.
Am J Reprod Immunol
Eslaminia F, Fakhri F, Baig MR, Sapaev I, Bayramdurdi S, Mohammad-Rezaei M.
PMID: 42905948 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 336829    Seite 1 von 16842  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1